Troy– Author –
-
ENCell Secures US Clinical Manufacturing Contract for Ingenium’s AML-Targeting NK Cell Therapy, ‘gengleucel’
KBR South Korea Overview ENCell, a CDMO specializing in cell and gene therapies, has secured a manufacturing contract for Ingenium Therapeutics' allogeneic NK cell therapy candidate, 'gengleucel,' for U.S. clinical trials. This therapy t... -
Biosero Unveils Self-Correcting Bioprocessing Platform to Accelerate Pharma R&D Automation
Biosero USA Overview Biosero has introduced a self-correcting platform advancing bioprocessing automation in pharmaceutical R&D. Future systems are projected to adapt protocols in real-time based on process analytical data, learning ... -
US Policy Shift Reshapes Biomanufacturing Supply Chain: Fujifilm Diosynth, Japan Government Drive Asia’s Rise as Key Hub
BioProcess Insider USA Overview The U.S. policy pivot regarding China's biotechnology sector is driving a global biomanufacturing supply chain restructuring. Fujifilm Diosynth Biotechnologies is pursuing over $4 billion in global expansi... -
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ... -
Laboratories Accelerate Shift to Automated Adherent and Suspension Cell Culture Platforms with CellXpress.ai Supporting Diverse Cell Types
News-Medical.Net UK Overview Laboratories are rapidly transitioning to automated adherent and suspension cell culture platforms like the CellXpress.ai system. This platform supports diverse cell types including 2D adherent, suspension, a... -
Lonza, Samsung Biologics, and Catalent Lead 2026 Biologics CDMO Market, Driven by AI Manufacturing & APAC Expansion
Towards Healthcare Unknown Overview Lonza, Samsung Biologics, and Catalent are identified as key players leading the 2026 biologics CDMO market. Lonza excels in end-to-end multi-modality and scientific innovation, Samsung Biologics in la... -
Immersive Biotech Energy Natural Resources Platform Market Leverages AI and Sensor Networks for Optimization
Digital Journal Canada Overview This article provides an overview of a market research report published by Digital Journal. The Immersive Biotech Energy Natural Resources Platform market utilizes AI-powered machine learning models to int... -
Bioprocessing’s ‘AI’ Demystified: Machine Learning Integrates with Existing Tech, Emphasizing Real-time Data at 2026 Summit
Mewburn Ellis UK Overview Discussions at the 2026 Global Bioprocessing & Biotechnology Summit clarified that 'AI' in bioprocessing refers not to large language models, but to the integration of machine learning into existing modeling... -
CellXpress.ai System Automates Brain Organoid Generation from iPSCs, Boosting Reproducibility and Efficiency for Neuroscience Research
News-Medical.Net UK Overview The CellXpress.ai automated cell culture system has been developed for the automated generation of brain organoids from iPSCs. Integrating liquid handlers, incubators, imagers, and machine learning-assisted i... -
Frederick National Lab Establishes High-Throughput Tumor Organoid Platform Using MIMETAS OrganoPlate for Precision Oncology
Frederick National Laboratory for Cancer Research USA Overview The Frederick National Laboratory for Cancer Research has established an advanced tumor organoid platform for precision oncology, leveraging MIMETAS' perfusion-enabled, high-...
